Dow Is Down Triple Digits on ECB Inaction

First Solar(FSLR) shares surged 21.2% after the solar panel company exceeded second-quarter estimates and hiked its full-year revenue outlook the previous day.

Bristol-Myers Squibb (BMY) suspended a mid-stage study of its experimental hepatitis C drug BMS-094 due to a serious safety issue said to heart failure, according to ISI Group analyst Mark Schoenebaum.

BMS-094 was the sole reason behind Bristol-Myers' $2.5 billion acquisition of Inhibitex last January.

Shares tumbled 8.6%.

American International Group(AIG) is looking to buy back a large amount of its shares from the government in a push that could make the U.S. a minority shareholder by the fall and allow the insurer to fully repay its bailout sooner than expected, the Journal reported, citing people familiar with the company's thinking.

Shares rose 0.84% in after hours after the company reported second-quarter operatings earnings per share of $1.06, which beat 60 cents consensus of analysts polled by Bloomberg.

The source of Wednesday's trading problem in about 150 stocks was traced to Knight Capital Group(KCG) , which said its market-making unit had suffered a software glitch that was interfering with its system's interaction with the New York Stock Exchange.

Knight Capital said in a press statement released Thursday that it has traded out of its entire erroneous trade position, which has resulted in a realized pretax loss of about $440 million.

Shares collapsed 63% on Thursday and were dipping another 19% after-hours.

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.